In this video, Eleonora Teplinsky, MD, discusses results of the HER2CLIMB-05 study, showing that adding tucatinib to first-line maintenance therapy improved patient outcomes in HER2-positive ...
Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...
On the first Sunday of November, when the majority of the United States set their clocks an hour earlier, the resulting ...
The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...
A 63-year-old Vietnamese-speaking man with a history of scleritis in the left eye, epiretinal membrane, dry eye syndrome and ...
HHS has announced proposed regulations that, if finalized, would limit access to gender-affirming care in minors and ...
Individuals with epilepsy and their caregivers want improved communication and a broader base of information from their ...
Patients with irritable bowel syndrome could benefit from using an AI-enhanced digital collaborative care model that combines ...
Results showed chondral defects of the knee treated with matrix-assisted autologous chondrocyte implantation may yield a high ...
Goals-of-care conversations can help clinicians align treatment with patient preferences. Documenting those discussions can ...
Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...
The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback